The Kansas City Area Life Sciences Institute released a report that says Kansas City needs more venture capital for its biotech industry.
Just how much venture capital? That is up for debate.
Wayne Carter, Life Sciences Institute CEO, said $100 million is the common amount thrown around in conversation regarding Kansas City’s need, and while “it’s a good place to start, it’s not enough,” he said.
“Saying we need $100 million in venture capital funding is not the end game,” he said. “We need to create an entire ecosystem of funding.”
